Ryan Camire, PhD

Kymera Therapeutics
Watertown, Massachusetts, United States

I am an immunologist at Kymera Therapeutics with broad expertise in innate and lymphoid cell biology and animal inflammatory disease models.

Presentation(s):

• 0930: Potent and Selective Oral IRF5 Degrader, KT 579, Blocks Pro-Inflammatory Cytokines and Reduces Joint Swelling in a Mouse Model of Rheumatoid Arthritis

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose